HDL PARTICLE MEASUREMENTS - IMPACT FOR DIAGNOSIS AND THERAPY

被引：10
作者：
BARD, JM
FRUCHART, JC
机构：
[1] INST PASTEUR, SERLIA, 1 RUE PROFESSEUR CALMETTE, F-59019 LILLE, FRANCE
[2] INST PASTEUR, INSERM, UNITE 325, F-59019 LILLE, FRANCE
来源：
CLINICAL BIOCHEMISTRY | 1993年 / 26卷 / 02期
关键词：
D O I：
10.1016/0009-9120(93)90030-A
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
[No abstract available]
引用
收藏
页码：65 / 68
页数：4
相关论文
共 26 条
[1]  
ALAUPOVIC P, 1982, RES CLIN LAB, V12, P3
[2]   SUBPOPULATIONS OF APOLIPOPROTEIN-A-I IN HUMAN HIGH-DENSITY LIPOPROTEINS THEIR METABOLIC PROPERTIES AND RESPONSE TO DRUG-THERAPY [J].
ATMEH, RF ;
SHEPHERD, J ;
PACKARD, CJ .
BIOCHIMICA ET BIOPHYSICA ACTA, 1983, 751 (02) :175-188
[3]   CHOLESTEROL EFFLUX FROM CULTURED ADIPOSE-CELLS IS MEDIATED BY LPAI PARTICLES BUT NOT BY LPAI-AII PARTICLES [J].
BARBARAS, R ;
PUCHOIS, P ;
FRUCHART, JC ;
AILHAUD, G .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1987, 142 (01) :63-69
[4]   EFFECT OF PRAVASTATIN, AN HMG COA REDUCTASE INHIBITOR, AND CHOLESTYRAMINE, A BILE-ACID SEQUESTRANT, ON LIPOPROTEIN PARTICLES DEFINED BY THEIR APOLIPOPROTEIN COMPOSITION [J].
BARD, JM ;
PARRA, HJ ;
DOUSTEBLAZY, P ;
FRUCHART, JC .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1990, 39 (03) :269-273
[5]   A MULTICENTER COMPARISON OF THE EFFECTS OF SIMVASTATIN AND FENOFIBRATE THERAPY IN SEVERE PRIMARY HYPERCHOLESTEROLEMIA, WITH PARTICULAR EMPHASIS ON LIPOPROTEINS DEFINED BY THEIR APOLIPOPROTEIN COMPOSITION [J].
BARD, JM ;
PARRA, HJ ;
CAMARE, R ;
LUC, G ;
ZIEGLER, O ;
DACHET, C ;
BRUCKERT, E ;
DOUSTEBLAZY, P ;
DROUIN, P ;
JACOTOT, B ;
DEGENNES, JL ;
KELLER, U ;
FRUCHART, JC .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1992, 41 (05) :498-503
[6]  
BARD JM, IN PRESS COMP EFFECT
[7]  
BREWER HB, 1990, DISORDERS HDL, P51
[8]  
CAMBIEN F, 1990, CIRCULATION, V348, P1380
[9]  
CASTRO GR, 1984, J LIPID RES, V25, P58
[10]  
CHEUNG MC, 1982, J LIPID RES, V23, P747
123